Precision Medicine

c-Met as an Emerging Target in Advanced Colorectal Cancer

John Strickler, MD
c-MET as an Emerging Target in Advanced Lung Cancer

Charu Aggarwal, MD, MPH
Evolving Management of HER2 Low and Ultralow Breast Cancer

Adrienne G. Waks, MD
Management of HER2 + Biliary Tract Cancers

Shubham Pant, MD, MBBS
Targeting HER2 in Colorectal Cancer

John Strickler, MD
Molecular Testing and the Implications for 1L Therapy in Stage IV EGFRm NSCLC

Charu Aggarwal, MD, MPH
Advances in the Management of Stage III NSCLC –Impact of the LAURA Clinical Trial

Charu Aggarwal, MD, MPH
Prostate Cancer with NTRK Fusion

Martin F. Dietrich, MD, PhD
NTRK Fusions, What’s Next? A Discussion on the Current Landscape of NTRK Fusion Therapeutic Management

Martin F. Dietrich, MD, PhD
STMI-NTRK mutated Metastatic Breast Cancer

Martin F. Dietrich, MD, PhD
NTRK Mutated Pancreatic Cancer

Martin F. Dietrich, MD, PhD
Perioperative Therapy and esNSCLC – ALINA Improves Outcomes for ALK Mutated NSCLCs

Charu Aggarwal, MD, MPH; Eric Vallieres, MD